With respect to gender, the SOCS5 and SOCS7 transcript levels of MS females (0.92 ± 0.05 and 0.9± 0.03 respectively) were similar to those of the control group (1.007 ± 0.06 and 1.008 ± 0.06) (p = 0.05). This evidence concerns the gene SOCS7 and myeloid sarcoma.